Showing results (21-30 of 174) with videos related to
Sort By:
Pageof 18
Human Immunology|May 25, 2006
Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunityLee H Bouwman, Bart O Roep, Anja RoosFrontiers in Medicine|July 29, 2022
From Disease and Patient Heterogeneity to Precision Medicine in Type 1 DiabetesNicoline H M den Hollander, Bart O RoepCurrent Opinion in Endocrinology, Diabetes, and Obesity|June 18, 2013
Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetesMenno van Lummel, Arnaud Zaldumbide, Bart O RoepNature Reviews. Immunology|December 2, 2004
Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetesBart O Roep, Mark Atkinson, Matthias von HerrathNederlands Tijdschrift Voor Geneeskunde|April 13, 2012
[Immunotherapy for type 1 diabetes mellitus (DM1)]Cornelis R van der Torren, Bart O RoepClinical Immunology (Orlando, Fla.)|February 29, 2008
Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetesSrinath Sanda, Bart O Roep, Matthias von HerrathTrends in Endocrinology and Metabolism: TEM|April 21, 2016
Neoantigens and Microenvironment in Type 1 Diabetes: Lessons from Antitumor ImmunityMaria J L Kracht, Arnaud Zaldumbide, Bart O RoepAnnals of the New York Academy of Sciences|February 9, 2005
Enhancing the sensitivity of assays to detect T cell reactivity: the effect of cell separation and cryopreservation mediaTimothy I M Tree, Bart O Roep, Mark PeakmanAnnals of the New York Academy of Sciences|November 30, 2006
A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell WorkshopTimothy I M Tree, Bart O Roep, Mark PeakmanThe Lancet. Diabetes & Endocrinology|December 12, 2018
Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicineBart O Roep, Daniel C S Wheeler, Mark PeakmanPageof 18